Please login to the form below

Not currently logged in
Email:
Password:

CAD106

This page shows the latest CAD106 news and features for those working in and with pharma, biotech and healthcare.

AZ gets $100m from Lilly as Alzheimer's drug progresses

AZ gets $100m from Lilly as Alzheimer's drug progresses

Meanwhile, Novartis and Amgen are co-developing a BACE inhibitor called CNP520 in combination with investigational immunotherapy CAD106 in people at risk of developing AD dementia, recently starting a phase

Latest news

More from news
Approximately 1 fully matching, plus 1 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Clark Health Communications

Clark Health Communications (CHC) is an independent, award-winning health and medical communications agency. Our collaboration with experts and advocates enhances...

Latest intelligence

Developing advocacy in the pharmaceutical industry.
The importance of advocacy programmes...
GDPR and events. What does the pharma industry need to know?
Many people in the pharma industry still aren’t following the rules set out by the GDPR when it comes to running events and attending tradeshows. But with eye-watering fines for...
Digital trends in B2B sales - how far behind is Pharma?
The modern approach to B2B sales is data-driven, and enabled by digital tools....

Infographics